Hundreds of free pizzas to be given out at new takeaway - here's how to get yours
Caprinos Pizza will open a new store at Lansdowne Crescent with a pizza party from 5pm on Wednesday, July 23.
To celebrate the occasion, Caprinos Bournemouth will be offering free pizzas to walk-in customers between 5pm and 6pm.
READ MORE:
Co-founders of Caprinos Pizza Gul Nawaz and Khalil Rehman said: 'We can't wait to welcome our first customers through the doors and serve our delicious pizzas to a new audience.
Caprinos will hand out hundreds of free pizzas this week (Image: Caprinos) "With our local franchisee, the new store is poised to become a vital part of the local community, showcasing our commitment to innovative flavours, quality, and affordability. We can't wait to introduce Caprinos to local consumers and are confident it will soon become the go-to spot for pizza lovers in Bournemouth.'
Customers will be able to try Caprinos' much-loved, affordable pizzas, which champion innovative flavour combinations and high-quality ingredients. This includes favourites such as Asian classic mix with tandoori chicken, vegetarian supreme, and Caprinos special with tandoori chicken and spicy beef.
After 6pm, Caprinos will also be offering 50 per cent off all pizzas for delivery and collection on July 23 and 24 , enabling customers to purchase a medium pizza from £3.
This will be followed by a 25 per cent discount on delivery and collection across July 25 to 27.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
2 hours ago
- Yahoo
Asian Stocks Estimated To Be 12.7% To 26.2% Below Intrinsic Value
As global markets respond to favorable trade deal news, Asian equities have shown resilience amid ongoing tariff discussions and economic uncertainties. In this environment, identifying undervalued stocks—those trading below their intrinsic value—can offer potential opportunities for investors looking to capitalize on market inefficiencies. Top 10 Undervalued Stocks Based On Cash Flows In Asia Name Current Price Fair Value (Est) Discount (Est) Shin Maint HoldingsLtd (TSE:6086) ¥1174.00 ¥2321.82 49.4% Shenzhen KSTAR Science and Technology (SZSE:002518) CN¥23.34 CN¥46.18 49.5% Range Intelligent Computing Technology Group (SZSE:300442) CN¥51.15 CN¥101.32 49.5% Polaris Holdings (TSE:3010) ¥220.00 ¥433.40 49.2% Nan Ya Printed Circuit Board (TWSE:8046) NT$177.00 NT$350.10 49.4% LigaChem Biosciences (KOSDAQ:A141080) ₩139000.00 ₩277490.02 49.9% Hibino (TSE:2469) ¥2345.00 ¥4664.61 49.7% Heartland Group Holdings (NZSE:HGH) NZ$0.82 NZ$1.62 49.4% Forum Engineering (TSE:7088) ¥1206.00 ¥2405.10 49.9% Andes Technology (TWSE:6533) NT$274.50 NT$542.92 49.4% Click here to see the full list of 265 stocks from our Undervalued Asian Stocks Based On Cash Flows screener. Below we spotlight a couple of our favorites from our exclusive screener. Dongsung FineTec Overview: Dongsung FineTec Co., Ltd. is a South Korean company that manufactures and sells cryogenic insulation products, with a market cap of approximately ₩811.48 billion. Operations: The company's revenue segments include the Gas Business, generating approximately ₩23.03 billion, and Cooling Material, contributing around ₩609.47 billion. Estimated Discount To Fair Value: 26.2% Dongsung FineTec is trading at ₩27,950, significantly undervalued compared to its estimated fair value of ₩37,869.08. Its earnings are projected to grow at 22.6% annually, outpacing the Korean market's growth rate and reflecting robust financial health despite an unstable dividend track record. Recent quarterly results showed net income of KRW 9 billion, up from KRW 8.69 billion a year earlier, reinforcing its strong cash flow position in the Asian market. Our growth report here indicates Dongsung FineTec may be poised for an improving outlook. Click to explore a detailed breakdown of our findings in Dongsung FineTec's balance sheet health report. Nanjing Vazyme Biotech Overview: Nanjing Vazyme Biotech Co., Ltd provides technology solutions in life science, biomedicine, and in vitro diagnostics with a market cap of CN¥10.52 billion. Operations: Nanjing Vazyme Biotech Co., Ltd generates revenue through its technology solutions in life science, biomedicine, and in vitro diagnostics. Estimated Discount To Fair Value: 17.1% Nanjing Vazyme Biotech is trading at CN¥26.44, slightly below its fair value estimate of CN¥31.91, suggesting it may be undervalued based on cash flows. The company is expected to become profitable within three years, with earnings projected to grow 78.27% annually—surpassing market averages despite a low forecasted return on equity of 5.6%. A recent share buyback plan worth CN¥10 million aims to enhance shareholder value through potential equity incentives or employee stock ownership plans. Our expertly prepared growth report on Nanjing Vazyme Biotech implies its future financial outlook may be stronger than recent results. Delve into the full analysis health report here for a deeper understanding of Nanjing Vazyme Biotech. Zhejiang Yinlun MachineryLtd Overview: Zhejiang Yinlun Machinery Co., Ltd. focuses on the research, development, manufacturing, and sale of thermal management and exhaust gas post-treatment products, with a market cap of CN¥24.97 billion. Operations: The company generates revenue primarily from the sale of thermal management and exhaust gas post-treatment products. Estimated Discount To Fair Value: 12.7% Zhejiang Yinlun Machinery is trading at CN¥30.13, undervalued relative to its fair value estimate of CN¥34.53. Earnings grew 18.9% last year and are projected to rise 25.12% annually, outpacing the Chinese market's growth rate of 23.5%. Despite a lower future return on equity forecast of 16.1%, recent share buybacks totaling CN¥34.96 million may enhance shareholder value through equity incentives or employee stock ownership plans. According our earnings growth report, there's an indication that Zhejiang Yinlun MachineryLtd might be ready to expand. Click here and access our complete balance sheet health report to understand the dynamics of Zhejiang Yinlun MachineryLtd. Make It Happen Reveal the 265 hidden gems among our Undervalued Asian Stocks Based On Cash Flows screener with a single click here. Already own these companies? Link your portfolio to Simply Wall St and get alerts on any new warning signs to your stocks. Unlock the power of informed investing with Simply Wall St, your free guide to navigating stock markets worldwide. Interested In Other Possibilities? Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include KOSDAQ:A033500 SHSE:688105 and SZSE:002126. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
2 hours ago
- Yahoo
High Growth Tech Stocks in Asia Featuring Three Prominent Picks
As global markets experience a surge, with key indices like the S&P 500 and Nasdaq Composite reaching record highs due to favorable trade deals, the Asian tech sector is also capturing attention amidst hopes for extended tariff truces and economic growth. In this dynamic environment, identifying high-growth tech stocks involves looking at companies that are well-positioned to leverage technological advancements and capitalize on improving trade relations. Top 10 High Growth Tech Companies In Asia Name Revenue Growth Earnings Growth Growth Rating Accton Technology 22.05% 23.29% ★★★★★★ Gold Circuit Electronics 20.97% 26.54% ★★★★★★ Zhejiang Lante Optics 21.61% 23.73% ★★★★★★ PharmaEssentia 31.60% 57.71% ★★★★★★ Fositek 30.51% 37.34% ★★★★★★ Eoptolink Technology 32.53% 32.58% ★★★★★★ Zhejiang Meorient Commerce Exhibition 26.71% 35.89% ★★★★★★ eWeLLLtd 24.95% 24.40% ★★★★★★ Shengyi Electronics 26.23% 37.40% ★★★★★★ CARsgen Therapeutics Holdings 81.53% 96.08% ★★★★★★ Click here to see the full list of 168 stocks from our Asian High Growth Tech and AI Stocks screener. Here's a peek at a few of the choices from the screener. Gan & Lee Pharmaceuticals Simply Wall St Growth Rating: ★★★★☆☆ Overview: Gan & Lee Pharmaceuticals is a biopharmaceutical company focused on the research, development, production, and sale of insulin analog APIs and injections in China with a market cap of approximately CN¥36.43 billion. Operations: Gan & Lee Pharmaceuticals primarily generates revenue through the development, production, and sale of insulin and related products, amounting to approximately CN¥3.47 billion. The company's operations are centered in China, focusing on biopharmaceutical advancements in insulin analogs. Gan & Lee Pharmaceuticals, a trailblazer in diabetes care, recently secured approval for its insulin aspart injection in Argentina, signaling robust expansion within Latin America's critical healthcare markets. This strategic move aligns with the rising demand for cost-effective diabetes treatments in regions grappling with high diabetes prevalence and healthcare costs. Impressively, Gan & Lee's revenue and earnings have been outpacing the Chinese market with annual increases of 19.5% and 26.8%, respectively. The firm's commitment to innovation is underscored by its R&D spending, which has consistently amplified its product pipeline and market competitiveness. Get an in-depth perspective on Gan & Lee Pharmaceuticals' performance by reading our health report here. Evaluate Gan & Lee Pharmaceuticals' historical performance by accessing our past performance report. Wuhan Dameng Database Simply Wall St Growth Rating: ★★★★☆☆ Overview: Wuhan Dameng Database Company Limited specializes in database product development services within China and has a market cap of CN¥26.47 billion. Operations: The company generates revenue primarily from data processing services, amounting to CN¥1.14 billion. Wuhan Dameng Database has demonstrated robust growth, with a notable 22.6% annual revenue increase and an earnings surge of 28.3% over the past year, outpacing the broader Chinese software industry's average. This performance is underpinned by strategic shareholder decisions, such as the recent approval of a significant financial cooperation agreement, enhancing its competitive edge in tech innovation. The company also prioritizes R&D investments, ensuring sustained advancement and market relevance in a rapidly evolving digital landscape. Unlock comprehensive insights into our analysis of Wuhan Dameng Database stock in this health report. Examine Wuhan Dameng Database's past performance report to understand how it has performed in the past. Dongguan Tarry ElectronicsLtd Simply Wall St Growth Rating: ★★★★★☆ Overview: Dongguan Tarry Electronics Co., Ltd. operates in China, producing and distributing precision die cutting products, foam protective film tapes, insulation heat conduction products, EMI shielding products, sewing and high frequency earmuffs, headbands, and assembly automation equipment with a market cap of CN¥7.35 billion. Operations: The company generates revenue primarily from its manufacturing industry segment, which accounts for CN¥2.77 billion. Its diverse product offerings include precision die cutting products and EMI shielding solutions. Dongguan Tarry Electronics has carved a niche in the high-growth tech sector in Asia, with a remarkable annual revenue growth of 23.6% and earnings growth of 26.6%. This performance is bolstered by its strategic focus on R&D, spending significantly to stay ahead in innovation within the electronics industry where it outperformed sector growth by over 160% last year. Recent corporate activities including leadership changes and shareholder meetings suggest proactive governance, poised to sustain its competitive edge and drive future growth amidst evolving market demands. Navigate through the intricacies of Dongguan Tarry ElectronicsLtd with our comprehensive health report here. Explore historical data to track Dongguan Tarry ElectronicsLtd's performance over time in our Past section. Seize The Opportunity Click here to access our complete index of 168 Asian High Growth Tech and AI Stocks. Shareholder in one or more of these companies? Ensure you're never caught off-guard by adding your portfolio in Simply Wall St for timely alerts on significant stock developments. Elevate your portfolio with Simply Wall St, the ultimate app for investors seeking global market coverage. Curious About Other Options? Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. Find companies with promising cash flow potential yet trading below their fair value. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include SHSE:603087 SHSE:688692 and SZSE:300976. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
New York Times
2 hours ago
- New York Times
Inside Liverpool's commercial juggernaut: New Adidas deal, 1.7bn engagements and why Asia matters
According to figures from Blinkfire Analytics, Liverpool had 1.7billion engagements across all social media platforms last season — more than the top 10 teams in the NFL or the NBA combined. There were 60m alone on the April day when Arne Slot's side clinched the Premier League title. Yet that is just one way in which the club's off-field operation has mushroomed in recent years. Over the past decade, commercial revenue has almost tripled. The last set of accounts for 2023-24 was significant in that, for the first time, commercial income (£308million) was more than half of total revenue (£614m). It was also the first time in the Premier League era that they had surpassed arch-rivals Manchester United (£303m) commercially. Advertisement 'There's been a step-change in terms of our revenue, but there's still a lot of room for us to grow,' Liverpool's chief commercial officer Ben Latty tells The Athletic. 'The potential is huge. I believe we're only just getting started in terms of where we can go as a commercial business. We have got the right people and the right structure in place to really kick on now.' Out-performing United or trying to reel in Manchester City (£344million), the only Premier League club with a higher income commercially, isn't what drives Latty and his staff, who are dotted around offices all over the world. He insists he 'wouldn't even be able to tell you what their commercial numbers are'. Instead, Liverpool's ambition revolves around maximising revenues from streams they can influence. 'Controllable revenue — matchday and commercial — is what I'm focused on,' Latty says. 'Media money is great but, to an extent, it's based on the on-pitch performance. We have to be a football club which is sustainable in everything we do.' Latty, who reports to Liverpool's CEO Billy Hogan, was promoted to the role of chief commercial officer in 2024, two years after returning to the fold as commercial director, having stepped down as head of global partnership sales in 2021 to join a group in Bristol operating professional teams in football, rugby union and basketball. The club have set up partnerships, with staff permanently based in Hong Kong, Japan, Singapore, Boston and New York in the United States, and in London as well as on Merseyside at home. Multi-million pound deals have been struck with high-profile blue-chip U.S.-based brands such as mobile-phone firm Google Pixel, fitness company Peloton, logistics and shipping giants UPS and digital strategists Orion Innovation. But the importance of the Asian market to Liverpool remains as strong as ever. According to the club's data, they have close to 250million fans across the continent, and it is their biggest region for retail revenue. Advertisement Nine of Liverpool's 20 standalone retail stores across the world are in Asia, with the latest opening its doors in Hong Kong last week. They also have 48 official supporters' clubs spread across the continent. That is part of the appeal for shirt sponsors Standard Chartered and training kit sponsors AXA, as well as official partners such as Japan Airlines and Tokyo-based publisher Kodansha. Liverpool's current pre-season tour, with money-spinning friendly matches in Hong Kong and Japan, ticks a lot of boxes. 'When it comes to tours, we always assess the market and look at different options both east and west,' Latty says. 'Before we made any decisions, we sat down with (sporting director) Richard Hughes, (his assistant) David Woodfine, (director of medicine and performance) John Power and others to go through all the options available. 'Some will be questioned based on football suitability, training facilities, et cetera. Football preparation is paramount, but the football-operations team understand the commercial value of these tours, too. For us, it's about bringing the club closer to fans who maybe can't get to Anfield.' Twice during Brendan Rodgers' reign as manager, pre-season tours to Asia also involved fixtures in Australia. The only time Liverpool have gone there since 2015 was for a post-season friendly in Sydney in 2017. Was it ever on the agenda to visit Australia this time? 'There were some reports, but it was nowhere near advanced,' Latty says. 'We always look at it. We never rule it out, but for this tour specifically, the idea was that we would do these two games and then get back to Anfield. 'We would have looked to play another game at Anfield on top of Athletic Club (the Spanish side visit for two back-to-back games on Monday, August 4), but the success of the team meant we have the Community Shield to play (on August 10) before the Premier League game against Bournemouth on the Friday night (August 15). That meant the window was reduced.' Advertisement In the past, Liverpool alternated their pre-season tours between the U.S. and Asia. How about 2026? 'We always start to look at our options a year out,' Latty says. 'That will be a mix of speaking to promoters or looking at how we could do it ourselves. If you do it yourself, you take some of that risk and back yourself in terms of filling stadia. The football side guides us in terms of what's best for the team, and then you also take into account what's going to give you commercial security and enable you to make the most of the window available to us.' The links between the club's sponsors and Asia are clear, but there was no contractual obligation to play in either Hong Kong or Japan this summer. 'There are so many variables,' Latty explains. 'Stadium availability, opposition availability, making sure there are the right training facilities. There are no guarantees. But we know when a partner is focused on a certain market and if the stars align, then we try to make it work.' Current deals with Standard Chartered and sleeve sponsor Expedia run until 2027, with discussions over possible extensions due to begin imminently. 'We'll be starting that process, both in terms of having discussions with the incumbent and naturally you'd expect us to go and talk to the market as well,' Latty says. 'At this time, I don't believe there's any bigger football club than Liverpool.' There's the strange scenario on this tour of Liverpool playing in last season's Nike kit as their new deal with Adidas doesn't begin until August 1. It's down to the fact the start of Nike's five-year contract was delayed because the 2019-20 season was extended into the July due to a three-month hiatus enforced by the Covid-19 pandemic. Liverpool will wear Nike gear for the final time in a while against Yokohama F. Marinos at Nissan Stadium today (Wednesday) before flying home. The big Adidas launch will follow on Friday, with the flagship club store at Anfield reopening having undergone a major summer makeover. 'It's just the reality of the situation,' Latty says. 'When you think back to when we started the partnership with Nike, it was late because of Covid. One thing I will say is that Nike have been incredible. They said they would be good partners until the very end and they've been true to their word. In terms of providing the equipment and kit needed for this tour, they have delivered everything we asked for. Advertisement 'You tend to launch a new kit in May and potentially wear it for the final game of a season, depending on the significance of the fixture. We haven't been able to do that, but August 1 will be big for us.' Latty insists there was never any prospect of an agreement being reached where Adidas would take over a few months early: 'We were always going to honour the contract with Nike. When we first entered into discussions with Adidas, it was always clear when we could start the partnership and everyone knew exactly where they stood. It won't happen again and won't really impact us.' It means Liverpool have three new kits to launch in a short period of time — a process that will be staggered in the coming days. The Adidas deal will certainly be more profitable for them than the Nike one. Figures remain confidential, and it will be partly linked to sales and team performance, but the yearly windfall will be a lot more than the figure of £60million per year which had previously been mooted. A new club mobile app has been launched and, under the terms of the contract, Liverpool will continue to have the freedom to commission and sell their own branded merchandise through the club's retail operations. 'With kit deals, there are so many variables,' Latty adds. 'It's really hard to compare a kit deal with Liverpool to a kit deal with a competitor. The way we run our merchandising business is completely different to most other clubs as we do everything ourselves. Some clubs are happy to outsource it. 'For us, having flexibility and ensuring we get the product into the hands of our fans around the world through the right distribution network is really important. 'We had record kit sales year on year (with Nike). It was a competitive situation, and varying factors meant that Adidas were the party we moved forward with. They have been great in that, as long as it doesn't impact their business, we can do what we want. That's a successful part of the merchandising business we've got as we look to keep growing. 'As Billy Hogan said recently, we're one of the biggest clubs in the world and we want to act like it. That's the case both on and off the field.'
